@conference {968, title = {Long-term grey matter structural changes in the transition from chronic migraine to episodic migraine}, booktitle = {8th Congress of the European Academy of Neurology}, year = {2022}, month = {2022}, abstract = {

Background and aims: The objective was to assess grey matter longitudinal changes in patients with chronic migraine (CM) who reverse to episodic migraine (EM) compared to those who do not reverse.

Methods: High-resolution 3D brain T1-weighted Magnetic Resonance Imaging data were obtained twice from migraine patients. The first acquisition was performed immediately after the first visit to the Headache Unit, before taking preventive treatments. The second timepoint was at least three years after the first acquisition. From the longitudinal pipeline of FreeSurfer (v6.0), the mean values of cortical thickness, surface area and grey matter volume of 68 cortical, 14 subcortical regions and the cerebellum were extracted. Longitudinal changes between patients with CM and those who reversed to EM were assessed with linear
mixed-effects models, setting p\<0.05 (false discovery rate corrected) as threshold for statistical significance.

Results: 22 patients were included, and 10 of them (45.5\%) reversed to EM. No statistically significant differences of age (42.0+-9.0 years) and sex (21 women, 95.5\%) were found between patient groups. Higher statistically significant values of the three parameters in patients who reversed to EM were found in the pericalcarine, parietal, orbitofrontal cortex, and amygdala (Table 1, Figure 1). In contrast, lower values were detected in the cingulum, caudal middle frontal cortex, cerebellum, caudate nucleus and pallidum (Figure 2). In the insula, higher thickness but lower area was appreciated in patients who reversed.

Conclusion: Patients with CM who reverse to EM present distinct patterns of increased and decreased morphometric parameters propagated in the orbital frontal cortex and the cingulum, respectively.

Disclosure: Nothing to disclose.

}, author = {{\'A}lvaro Planchuelo-G{\'o}mez and Marchante-Re{\'\i}llo, Ginebra and Sierra, {\'A}lvaro and Garc{\'\i}a-Azor{\'\i}n, David and Mart{\'\i}n-Mart{\'\i}n, Carmen and de Luis-Garc{\'\i}a, Rodrigo and Aja-Fern{\'a}ndez, Santiago and Moro, Ra{\'u}l and Rodr{\'\i}guez, Margarita and Gonz{\'a}lez-Osorio, Y{\'e}sica and {\'A}ngel L. Guerrero} } @conference {967, title = {Objective measurement of pain related to cardiac surgery: a study using algometry}, booktitle = {8th Congress of the European Academy of Neurology}, year = {2022}, month = {2022}, abstract = {

Background and aims: Algometry is a safe and objective technique to quantify pain, up to now used in headache research, but to a lesser extent to assess pain related to surgery. We aimed to analyze the demographic characteristics of pain related to cardiac surgery, assessed using static algometry.

Methods: Adult patients consecutively undergoing cardiac surgery were prospectively recruited. Pressure pain thresholds (PPT) were measured in both sides of sternum manubrium, body (five measures) and xiphoid process, preoperatively and on days 1, 3 and 7 postoperatively. Linear mixed-effects models were employed to assess the longitudinal changes and results were corrected for multiple comparisons following a false discovery rate procedure.

Results: We included 70 patients (41.4\% female) with a median age of 67.5 years (range 26-85). Regarding the baseline values, PPT were significantly lower in women and patients older than 65 years. After the surgery, there was a significant reduction of PPT in all assessed regions, which was partially compensated after seven days. Moreover, postoperatively, differences associated with age disappeared and those associated with sex were almost negligible. These differences related to age and sex increased after seven days of surgery, but this difference was lower in comparison with the baseline situation (Table 1, Figure 1). Postoperative pain perception was significantly higher (lower PPT) in both sexes.

Conclusion: Pain related to cardiac surgery can be measured with algometry, mainly during first postoperative days. Differences in pain sensitivity related to age and sex decrease after surgery.

Disclosure: No conflict of interest.

}, author = {Segura-M{\'e}ndez, B{\'a}rbara and {\'A}lvaro Planchuelo-G{\'o}mez and Sierra, {\'A}lvaro and Garc{\'\i}a-Azor{\'\i}n, David and Velasco-Garc{\'\i}a, E. and Fuentes-Mart{\'\i}n, {\'A}. and S{\'a}nchez, C. and V{\'a}zquez-Alarc{\'o}n de la Lastra, I. and {\'A}ngel L. Guerrero and Carrascal, Yolanda} } @conference {940, title = {Evaluation of the burden of migraine on the partners lifestyle: a multicenter study}, booktitle = {International Headache Congress 2021}, year = {2021}, month = {2021}, publisher = {International Headache Society \& European Headache Federation}, organization = {International Headache Society \& European Headache Federation}, address = {Virtual Congress}, abstract = {

Objective: Migraine is a highly disabling disease that affects the patient{\textquoteright}s life, but its consequences on the patient{\textquoteright}s partner have been barely studied. The objective was to analyze these effects on romantic relationship, relationship with their children, friendship and work; as well as to evaluate caregiver burden and the presence of anxiety and/or depression.
Methods: Cross-sectional observational study. An online survey was filled by partners of migraine patients from five Spanish Headache Units. Questions about the four assessed areas and two scales to evaluate anxiety, depression and caregiver burden (Hospital Anxiety and Depression Scale and Zarit scale) were included. The presence of anxiety and depression was compared to the Spanish prevalence (6.7\% in both cases).
Results: Out of 176 registered responses, 155 were accepted. The sample included 86.5\% of women, with mean age 44.2 +- 10.4 years. Effects on partners were found on love relationship and items concerning children and friendships, with a minor impact at work. Partners showed a significant moderate burden according to the Zarit scale (p = 12/155 = 0.077 [0.041-0.131]; p \< 0.001) and a higher anxiety rate than the 6.7\% national prevalence (p = 23/155 = 0.148 [0.096-0.214]; p \< 0.001), but similar depression rate.
Conclusion: We found an impact on the patient{\textquoteright}s partners on the studied areas. Migraine is a disease that implies caregiver burden in the patient{\textquoteright}s environment with possible effect on anxiety levels.

}, url = {https://journals.sagepub.com/doi/pdf/10.1177/03331024211034005}, author = {Fern{\'a}ndez-Bermejo, Eva M and {\'A}lvaro Planchuelo-G{\'o}mez and Quintas, Sonia and Gonzalez-Martinez, Alicia and Garc{\'\i}a-Azor{\'\i}n, David and Sierra, {\'A}lvaro and {\'A}ngel L. Guerrero and Santos-Lasaosa, Sonia and Navarro-P{\'e}rez, Mar{\'\i}a P and Gonz{\'a}lez-Garc{\'\i}a, Nuria and D{\'\i}az-de-Ter{\'a}n, Javier and Ana B Gago-Veiga} } @article {909, title = {Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study}, journal = {Scientific Reports}, volume = {11}, year = {2021}, pages = {3846}, abstract = {

To date, two randomized, controlled studies support the use of candesartan for migraine prophylaxis but with limited external validity. We aim to evaluate the effectiveness and tolerability of candesartan in clinical practice and to explore predictors of patient response. Retrospective cohort study including all patients with migraine who received candesartan between April 2008-February 2019. The primary endpoint was the number of monthly headache days during weeks 8{\textendash}12 of treatment compared to baseline. Additionally, we evaluated the frequency during weeks 20{\textendash}24. We analysed the percentage of patients with 50\% and 75\% response rates and the retention rates after three and 6\ months of treatment. 120/4121 patients were eligible, aged 45.9 [11.5]; 100 (83.3\%) female. Eighty-four patients (70\%) had chronic migraine and 53 (42.7\%) had medication-overuse headache. The median number of prior prophylactics was 3 (Inter-quartile range 2{\textendash}5). At baseline, patients had 20.5 {\textpm} 8.5 headache days per month, decreasing 4.3 {\textpm} 8.4\ days by 3\ months (weeks 12{\textendash}16) and by 4.7 {\textpm} 8.7\ days by 6\ months (paired Student{\textquoteright}s t-test, p \< 0.001). The percentage of patients with a 50\% response was 32.5\% at 3\ months and 31.7\% at 6\ months, while the retention rate was 85.0\% and 58.3\%. The number of prior treatments (Odds ratio 0.79, 95\% CI 0.64{\textendash}0.97) and the presence of daily headache (Odds ratio 0.39, 95\% CI 0.16{\textendash}0.97) were associated with a lower probability of response. Candesartan showed beneficial effects in the preventive treatment of migraine in clinical practice, including patients with chronic migraine, medication-overuse headache and resistance to prior prophylactics.

}, issn = {2045-2322}, doi = {10.1038/s41598-021-83508-2}, url = {https://doi.org/10.1038/s41598-021-83508-2}, author = {S{\'a}nchez-Rodr{\'\i}guez, Carmen and Sierra, {\'A}lvaro and {\'A}lvaro Planchuelo-G{\'o}mez and Mart{\'\i}nez-P{\'\i}as, Enrique and {\'A}ngel L. Guerrero and Garc{\'\i}a-Azor{\'\i}n, David} } @article {887, title = {Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study}, journal = {The Journal of Headache and Pain}, volume = {21}, year = {2020}, month = {Jul}, pages = {94}, abstract = {Headache is one of the most frequent neurologic manifestations in COVID-19. We aimed to analyze which symptoms and laboratory abnormalities were associated with the presence of headache and to evaluate if patients with headache had a higher adjusted in-hospital risk of mortality.}, issn = {1129-2377}, doi = {10.1186/s10194-020-01165-8}, url = {https://doi.org/10.1186/s10194-020-01165-8}, author = {Trigo, Javier and Garc{\'\i}a-Azor{\'\i}n, David and {\'A}lvaro Planchuelo-G{\'o}mez and Mart{\'\i}nez-P{\'\i}as, Enrique and Talavera, Blanca and Hern{\'a}ndez-P{\'e}rez, Isabel and Valle-Pe{\~n}acoba, Gonzalo and Sim{\'o}n-Campo, Paula and de Lera, Mercedes and Chavarr{\'\i}a-Miranda, Alba and L{\'o}pez-Sanz, Cristina and Guti{\'e}rrez-S{\'a}nchez, Mar{\'\i}a and Mart{\'\i}nez-Velasco, Elena and Pedraza, Mar{\'\i}a and Sierra, {\'A}lvaro and G{\'o}mez-Vicente, Beatriz and Juan F Arenillas and {\'A}ngel L. Guerrero} }